Abacus Global Management (ABX) Q2 2026 Earnings Report

The call presented multiple strong operational and financial achievements — robust revenue growth (+30% YoY), substantial fundraising (H1 longevity inflows $544.2M), higher capital deployment (+62% YoY), realized gains (~25%), and margin expansion (55% adjusted EBITDA margin). Product and distribution milestones (interval fund launch, tokenization, Manning & Napier integration, and LifeARC adoption) signal durable strategic progress. Offsetting items include pressure in traditional asset-management fees (ETF outflows), higher operating expenses, modest near-term tech revenue, and a relatively small cash balance versus long-term debt. On balance, the highlights materially outweigh the lowlights and indicate positive momentum and trajectory for the business.

Management guided third-quarter adjusted net income of $26–$28 million and adjusted EPS of $0.26–$0.28, and reiterated full‑year adjusted net income of $100–$106 million and adjusted EPS of $1.00–$1.05 (guidance presented gross with an approximate 25% tax bridge to net equivalents); they said they are aiming for the top end of the ranges. The company beat Q2 guidance with adjusted net income of $27.1M and $0.28 EPS (May guidance: $24–$26M / $0.24–$0.26), reported Q2 adjusted EBITDA of $40M (up 27% YoY) and a 55% EBITDA margin, and highlighted operational momentum: Q2 capital deployed ~ $197.9M (YTD deployed $362M) with potential quarterly deployment of $150–$175M if securitization progresses, H1 longevity fund inflows of $544.2M (Q2 inflows ~$256.1M), fee‑paying AUM ~$3.2B (total AUM $3.5B) with a $5B year‑end AUM target, policy assets $383M, cash $23.4M, long‑term debt $290.8M, adjusted ROE 25% (+400 bps), annualized portfolio turnover ~2x, average realized gain on policy sales ~25%, tech/service fees YTD ~ $1M (management discussed a ~$3M projection), launch of the ABX Longevity Growth & Income interval fund and expected asset intake in Q3–Q4, and an anticipated increase in the 2026 dividend.